BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can two drugs reboot radioiodine therapy for tough thyroid cancers?
Disease control CompletedThis early-phase trial tested two drugs, vemurafenib and copanlisib, in 8 people with advanced BRAF-mutant thyroid cancers that had stopped responding to radioiodine therapy. The goal was to see if the combination could make tumors sensitive to radioiodine again and to find the s…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:34 UTC
-
Researchers examine current treatments for aggressive colorectal cancer
Knowledge-focused CompletedThis study looked back at medical records of 274 people with a specific type of advanced colorectal cancer (BRAF V600E mutation) to see what treatments they received and how well they worked. The goal was to understand real-world treatment patterns and outcomes, since there is no…
Matched conditions: BRAF V600E MUTATION POSITIVE
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC